Literature DB >> 33373098

Lack of efficacy of radiation therapy plus PD-L1 blockade for Merkel cell carcinoma arising in a patient with chronic active Epstein-Barr virus infection.

Ayaka Okazaki1, Kozo Nakai1, Nao Kusutani1, Riei Kamo1, Yoshie Fukunaga1, Kotaro Nagase2, Paul Nghiem3, Daisuke Tsuruta1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33373098      PMCID： PMC9440151          DOI： 10.1111/dth.14722

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN： 1396-0296            Impact factor:   3.858


× No keyword cloud information.
  7 in total

Review 1.  Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?

Authors:  Hiroshi Kimura
Journal:  Rev Med Virol       Date:  2006 Jul-Aug       Impact factor: 6.989

2.  No evidence of Epstein-Barr virus association with Merkel cell carcinoma.

Authors:  Maren Shaw; Simon Warren; Pamela Groben; Margaret L Gulley
Journal:  J Cutan Pathol       Date:  2006-09       Impact factor: 1.587

3.  Epidemiology of primary Merkel cell carcinoma in the United States.

Authors:  Maria Agelli; Limin X Clegg
Journal:  J Am Acad Dermatol       Date:  2003-11       Impact factor: 11.527

4.  Radiation Therapy is Associated with Improved Outcomes in Merkel Cell Carcinoma.

Authors:  Tobin Strom; Michael Carr; Jonathan S Zager; Arash Naghavi; Franz O Smith; C Wayne Cruse; Jane L Messina; Jeffery Russell; Nikhil G Rao; William Fulp; Sungjune Kim; Javier F Torres-Roca; Tapan A Padhya; Vernon K Sondak; Andy M Trotti; Louis B Harrison; Jimmy J Caudell
Journal:  Ann Surg Oncol       Date:  2016-06-01       Impact factor: 5.344

5.  Effectiveness of Combined Anti-programmed Death-ligand 1 Therapy and Radiotherapy for Metastatic Merkel Cell Carcinoma: Two Case Reports.

Authors:  Kanako Tsunoda; Masazumi Onishi; Shinpei Miura; Hiroo Amano
Journal:  Acta Derm Venereol       Date:  2020-08-18       Impact factor: 3.875

Review 6.  Merkel Cell Carcinoma: Therapeutic Update and Emerging Therapies.

Authors:  Alessia Villani; Gabriella Fabbrocini; Claudia Costa; Maria Carmela Annunziata; Massimiliano Scalvenzi
Journal:  Dermatol Ther (Heidelb)       Date:  2019-02-28

7.  Systemic immune suppression predicts diminished Merkel cell carcinoma-specific survival independent of stage.

Authors:  Kelly G Paulson; Jayasri G Iyer; Astrid Blom; E Margaret Warton; Monica Sokil; Lola Yelistratova; Louise Schuman; Kotaro Nagase; Shailender Bhatia; Maryam M Asgari; Paul Nghiem
Journal:  J Invest Dermatol       Date:  2012-11-29       Impact factor: 8.551
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.